FDA Approved: DOFETILIDE — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a generic version of dofetilide (brand Tikosyn) from Bionpharma Inc. under ANDA208625 for atrial fibrillation and atrial flutter.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Tikosyn (dofetilide)

Snippet

ORIG AP for DOFETILIDE (DOFETILIDE)